Hugo Fry
AeroLeads people directory · profile

Hugo Fry Email & Phone Number

Life Science Leader | Biotech | CEO | Executive | Board Member | Commercial, R&D, Industrial Affairs at Topas Therapeutics GmbH
Location: London, England, United Kingdom 17 work roles 3 schools
1 work email found @spmsd.com 4 phones found area 908, 693, and 121 LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 4 phones

Work email h****@spmsd.com
Direct phone (908) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Life Science Leader | Biotech | CEO | Executive | Board Member | Commercial, R&D, Industrial Affairs
Location
London, England, United Kingdom

Who is Hugo Fry? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Hugo Fry is listed as Life Science Leader | Biotech | CEO | Executive | Board Member | Commercial, R&D, Industrial Affairs at Topas Therapeutics GmbH, based in London, England, United Kingdom. AeroLeads shows a work email signal at spmsd.com, phone signal with area code 908, 693, 121, and a matched LinkedIn profile for Hugo Fry.

Hugo Fry previously worked as Chief Executive Officer at Topas Therapeutics Gmbh and Chief Business Officer and Managing Director at 20Med Therapeutics. Hugo Fry holds Finance from London Business School.

Company email context

Email format at Topas Therapeutics GmbH

This section adds company-level context without repeating Hugo Fry's masked contact details.

{first_initial}{last}@spmsd.com
86% confidence

AeroLeads found 1 current-domain work email signal for Hugo Fry. Compare company email patterns before reaching out.

Profile bio

About Hugo Fry

A results-driven Pharmaceutical/Biotech Executive and Life Science Leader with 30 years’ of senior management experience in large and medium multi-national companies, small startup Biotech, across multiple business models and therapeutic areas, in the UK, USA, France, Russia and Germany, delivering outcomes worth hundreds of millions of dollars. Possesses remarkable business and commercial acumen with extensive experience in R&D, Industrial Affairs and commercial launches. Leads with vision to drive the strategic direction of companies drawing on experience from multiple specialities, including fundraising, licensing and partnerships. A natural communicator able to build, collaborate and motivate internally and externally to achieve business objectives.A proven track record in both emerging and established markets, I drive success from early phase research and development through industrialisation to commercial launch — across a wide variety of therapeutic areas, business models and beyond borders.Challenge is critical to our growth as companies and individuals and I believe that individuals and companies can truly thrive when you give people the space to be brilliant. I enjoy an environment where we have the freedom to be innovative in developing new and exciting projects. As a leader, I work transversely to bring diverse teams together in a common purpose and am an enthusiastic and passionate communicator. I’m proud to serve as an executive leader, addressing complex issues in support of a mission to help people and patients working to prevent, ease or cure diseases.

Listed skills include Pharmaceutical Industry, Market Access, Pharmaceutical Sales, Strategy, and 38 others.

Current workplace

Hugo Fry's current company

Company context helps verify the profile and gives searchers a useful next step.

Topas Therapeutics GmbH
Topas Therapeutics Gmbh
Life Science Leader | Biotech | CEO | Executive | Board Member | Commercial, R&D, Industrial Affairs
AeroLeads page
17 roles · 32 years

Hugo Fry work experience

A career timeline built from the work history available for this profile.

Chief Executive Officer

Current

Hamburg, DE

Topas Therapeutics is advancing a highly differentiated and versatile approach to establish immune tolerance in autoimmune and immune-mediated diseases. Our proprietary, antigen-coupled nanoparticles, Topas Particle Conjugates, target liver sinusoidal endothelial cells to prompt anti-inflammatory immune responses and drive T cells toward tolerance.

Apr 2024 - Present

Chief Business Officer And Managing Director

Current

Enschede, NL

20Med’s mission is to establish a polymeric nanoparticles (PNP) platform that stands as a leading alternative to LNPs in the delivery of mRNAOur polymeric Nanoparticle platform is being applied to the development of several vaccines and therapeutics for human and animal health indications to help accelerate partnered programs toward clinical trials.

Oct 2023 - Present

Chief Executive Officer

London, England, GB

RQ Bio is dedicated to developing treatments and preventative therapies based on potent broad-spectrum mAbs to provide instant and long-lasting immunity for vulnerable people at risk of severe disease or death from existing, emerging and new viral infections.

Jan 2022 - Sep 2023

Life Science Leader | Pharmaceuticals And Biotech | Commercial, R&D, Industrial Affairs

Advisor | Board Member

Using breadth and depth as a Senior Leader in the Biopharmaceutical industry across Commercial, R&D and Industrial Affairs to advise Biotech organisations.

Jul 2021 - Jun 2022

Managing Director – Uk ► Commercial, Industrial, R&D | Innovative Healthcare Solutions

Paris, France, FR

Sanofi is a global biopharmaceutical company committed to healthcare solutions from prevention to treatment. We turn scientific discoveries into medicine to improve human health. Every day we dedicate our most important resource, our people, to support patients and families through their health journey.____________________As the Managing Director for the.

Jan 2017 - Jun 2021

Vice President ► Executive Leadership In Biosciences

London, GB

The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.____________________ABPI represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and.

May 2019 - Apr 2021

Board Member ► Executive Leadership In Biosciences

London, GB

The Association of the British Pharmaceutical Industry (ABPI) represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.____________________ABPI represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and.

Dec 2016 - Apr 2021

Vice President, Chief Marketing Officer ► Commercial Strategy | Business Development

FR

Sanofi Pasteur MSD was created to develop and commercialize vaccines originating from both companies’ pipelines to improve and promote public health in 19 European countries. ____________________In 2015, I was selected to lead as Vice President and Chief Marketing Officer for Sanofi Pasteur MSD. As the executive in charge of leading commercial strategy and.

Jan 2015 - Dec 2016

Global Project Leader, Lixisenatide Family ► Cross-Functional Team Leadership | Pharmaceuticals

Paris, France, FR

Selected as the Global Project Leader for the Lixisenatide family of products, I provided visionary leadership in this high visibility role with a vertically integrated team of over 1000 staff. I directed this fully integrated project as a ‘company within a company’ —building strategy and managing complex business initiatives in alignment with Sanofi’s.

Jan 2011 - Dec 2014

General Manager ► International Business | Revenue Growth | Integration Management

Prague 10, CZ

As the General Manager for Zentiva, I held full responsibility and accountability for this autonomous branded generic affiliate of Sanofi in Russia — overseeing a staff of >500.In this role, I was a member of the Global Zentiva Leadership team where I reported directly to the President of the organisation.» Delivered highly effective leadership resulting.

Oct 2010 - Jan 2011

Business Unit Director - Russia ► Commercial Operations | Oncology | Diabetes | Cardio-Hospital

Paris, France, FR

Running 3 Business Units in RussiaOncology, Diabetes, Cardio-Hospital

Sep 2008 - Oct 2010

Marketing Director - Russia ► Marketing Strategy | Portfolio Management

Paris, France, FR

Full marketing responsibility across the affiliate portfolio.

Jan 2007 - Sep 2008

Marketing Support Director - Global Marketing ► Franchise Management

Paris, France, FR

Working across all Global Marketing Franchises and top 7 affiliates.

Jan 2005 - Dec 2006

Brand Director | Gm | Product, Sales & Training Manager ► Regional & Global Roles

Suresnes, FR

1994 - 2003 ~9 yrs
3 education records

Hugo Fry education

Finance

London Business School

Leadership

Duke University

Bsc, Chemistry

The University Of Salford
FAQ

Frequently asked questions about Hugo Fry

Quick answers generated from the profile data available on this page.

What company does Hugo Fry work for?

Hugo Fry works for Topas Therapeutics GmbH.

What is Hugo Fry's role at Topas Therapeutics GmbH?

Hugo Fry is listed as Life Science Leader | Biotech | CEO | Executive | Board Member | Commercial, R&D, Industrial Affairs at Topas Therapeutics GmbH.

What is Hugo Fry's email address?

AeroLeads has found 1 work email signal at @spmsd.com for Hugo Fry at Topas Therapeutics GmbH.

What is Hugo Fry's phone number?

AeroLeads has found 4 phone signal(s) with area code 908, 693, 121 for Hugo Fry at Topas Therapeutics GmbH.

Where is Hugo Fry based?

Hugo Fry is based in London, England, United Kingdom while working with Topas Therapeutics GmbH.

What companies has Hugo Fry worked for?

Hugo Fry has worked for Topas Therapeutics Gmbh, 20Med Therapeutics, Zen Intelligence, Imbria Pharmaceuticals, and Rq Biotechnology Ltd..

How can I contact Hugo Fry?

You can use AeroLeads to view verified contact signals for Hugo Fry at Topas Therapeutics GmbH, including work email, phone, and LinkedIn data when available.

What schools did Hugo Fry attend?

Hugo Fry holds Finance from London Business School.

What skills is Hugo Fry known for?

Hugo Fry is listed with skills including Pharmaceutical Industry, Market Access, Pharmaceutical Sales, Strategy, Diabetes, Oncology, Global Marketing, and Clinical Development.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.